Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Meissl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cytokine|December 4, 2015
The good and the bad faces of STAT1 in solid tumoursKatrin Meissl, Sabine Macho-Maschler, Mathias Müller, et al.
The Journal of Cell Biology|December 21, 2005
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signalingDaniela Piazzolla, Katrin Meissl, Lucia Kucerova, et al.
Blood|March 11, 2006
A balance between Raf-1 and Fas expression sets the pace of erythroid differentiationCristina Rubiolo, Daniela Piazzolla, Katrin Meissl, et al.
Cancer Cell|August 4, 2009
Raf-1 addiction in Ras-induced skin carcinogenesisKarin Ehrenreiter, Florian Kern, Vanishree Velamoor, et al.
Cell Cycle (Georgetown, Tex.)|July 25, 2006
ERK and beyond: insights from B-Raf and Raf-1 conditional knockoutsGergana Galabova-Kovacs, Andrea Kolbus, Dana Matzen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Essential role of B-Raf in ERK activation during extraembryonic developmentGergana Galabova-Kovacs, Dana Matzen, Daniela Piazzolla, et al.
Frontiers in Immunology|December 22, 2018
The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor RecruitmentMatthias Parrini, Katrin Meissl, Mojoyinola Joanna Ola, et al.
Molecular Cell|September 25, 2007
RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor proteinDavid Matallanas, David Romano, Karen Yee, et al.
Oncoimmunology|October 10, 2015
<i>In vivo</i> tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activityMichaela Prchal-Murphy, Agnieszka Witalisz-Siepracka, Karoline T Bednarik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2019
NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial ImmunityNatalija Simonović, Agnieszka Witalisz-Siepracka, Katrin Meissl, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cytokine|December 4, 2015
The good and the bad faces of STAT1 in solid tumoursKatrin Meissl, Sabine Macho-Maschler, Mathias Müller, et al.
The Journal of Cell Biology|December 21, 2005
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signalingDaniela Piazzolla, Katrin Meissl, Lucia Kucerova, et al.
Blood|March 11, 2006
A balance between Raf-1 and Fas expression sets the pace of erythroid differentiationCristina Rubiolo, Daniela Piazzolla, Katrin Meissl, et al.
Cancer Cell|August 4, 2009
Raf-1 addiction in Ras-induced skin carcinogenesisKarin Ehrenreiter, Florian Kern, Vanishree Velamoor, et al.
Cell Cycle (Georgetown, Tex.)|July 25, 2006
ERK and beyond: insights from B-Raf and Raf-1 conditional knockoutsGergana Galabova-Kovacs, Andrea Kolbus, Dana Matzen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Essential role of B-Raf in ERK activation during extraembryonic developmentGergana Galabova-Kovacs, Dana Matzen, Daniela Piazzolla, et al.
Frontiers in Immunology|December 22, 2018
The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor RecruitmentMatthias Parrini, Katrin Meissl, Mojoyinola Joanna Ola, et al.
Molecular Cell|September 25, 2007
RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor proteinDavid Matallanas, David Romano, Karen Yee, et al.
Oncoimmunology|October 10, 2015
<i>In vivo</i> tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activityMichaela Prchal-Murphy, Agnieszka Witalisz-Siepracka, Karoline T Bednarik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2019
NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial ImmunityNatalija Simonović, Agnieszka Witalisz-Siepracka, Katrin Meissl, et al.
Pageof 3